What is a "food-derived bioactive technology" and a "functional food"?
It is becoming increasingly accepted by the scientific community that there are links between specific food groups and their capacity to help reduce the risk of certain diseases. For example, some compounds specifically found in broccoli have been shown to reduce the risk of some cancers. Consuming the actual food may be insufficient to maximise the health benefit due to a number of factors including: the quantity of the food that would need to be consumed; the frequency with which it would need to be consumed; and the way in which the food is prepared prior to consumption.

These health-promoting compounds can be extracted from the food source (called a food-derived bioactive technology) and reintroduced into consumer-friendly lifestyle products which are proven to maintain health (a functional food). Therefore, instead of eating four large servings of broccoli per week, the same benefit may be technically delivered via a 250ml orange juice drink containing the bioactive if consumed once per week.

How is Provexis differentiated from other companies in the market?
Provexis is an evidence-based business which means that we only develop food-derived bioactive technologies and functional food products that have been scientifically proven to deliver a health benefit. This is a different approach from those that promote functional food products in a more generic way with less scientific evidence. We believe that functional food products with strong scientific proof carrying health claims and endorsements will endure and prosper as this rapidly growing market matures.

Provexis is also differentiated with regard to our speed-to-market credentials and the fact that we can create shareholder value via a combination of technology licensing and own brand development.

What food-derived bioactive technologies are being developed by Provexis?
Provexis has developed Fruitflow, a patented extract from tomato that has been proven to inhibit blood platelet aggregation, thereby reducing the risk of thrombosis. A thrombosis is an aberrant blood clot that can lead to heart attack and stroke. Provexis has integrated Fruitflow into a fruit juice beverage called Sirco. When launched - initially in the United Kingdom - it will be the first functional food carrying the claim Helps maintain a healthy heart and benefit circulation with a measurable benefit within hours of consumption.

Provexis is developing a proprietary extract from a special breed of broccoli (non-GMO) which is enriched in compounds known to reduce the risk of specific cancers. Provexis intends to use this food-derived bioactive to underpin a new range of functional beverages with scientifically proven protective properties.

In addition, Provexis is developing a patented extract from plantain with a view to developing a novel medical food for the dietary management of Inflammatory Bowel Disease, specifically Crohns Disease in the first instance.

driver, just a little ;)

still no interest ? as long as the drinks sell there really isn't too much downside to this. there's still a raft of outlets for pxs to target. that could mean a steady flow of news about new outlets and then hopefully some good sales figures announcements.

lovely rise here ,too :)

Hi. Have been accumulating for a while. Big potential here IMO. V little downside for health products at the moment + some big distribution deals in the pipeline apparently.

down today. no reason why that i can see, but , then again, it can't really go up everyday :)

Fell on v low volume. ??

No interest here!!

I see from the provexis website that the products will be selling in 884 outlets in the UK by end of jan '06. EOY is 31.03.06 so the figures should be positive. We shall see. (.6mfor 04/5)

From 23.01.06

Provexis, the nutraceutical company that develops scientifically-proven functional and medical foods, announces a significant increase in the number of distribution outlets for its Sirco heart health juice drink, under the terms of its most recent distribution agreement with a market leading supermarket chain.

johnny, that's already been posted. not much to do or say for the time being except wait for some figures or news about new distribution agreements.

Bosley Hi.

Am surprised at the lack of interest. As far as I can see there are no threads on advfn or fyb for this co.

The only downside AFAICS is if the product is so gross that it doesn't sell. But I can't see that as likely.

Has anyone found Sirco instore yet?

johnny the fox
advfn thread
www.advfn.com/cmn/fbb/thread.php3?id=9310489

yes.it's in lot's of stores here in the notts area.. my fridge has a good supply, it tastes good, and if it help me to avoid having a stroke..i'll keep drinking it. cheap at half the price..i can see half the county on it ,if they know what's good for them.that can only mean one thing for the share price..cheer's...

Hi, folk. Some old pals here which is encouraging. Having a look at recommendation of Bos who made me a killing on SEO. This one could avoid the killing! Can't find any projections of sales value. If there are 800+ stores selling it how many each. Presumably margin is not that great, given the power of the s-m's.

Eric

Be wary of competition.

Asda have "innocent" on half price promotion right now, i'll assume that is to get
people to try their drinks as there cannot be that many people around prepared
to pay 3 quid for a carton of juice no matter how nice, natutral and healthy it is.

Look at the health milk drinks, Actimel started the advertising blitz and now there's
loads of these bacteria drinks competing with each other.

So Provexis might have a great drink but there will be so many others lining up to
compete with them so if the shares have a good run it might be sensible to bank
profits, i would'nt chase the share price as the market cap is already quite high.

ravey davey gravy, (great name btw and many congratulations on champinvest), it is another health drink although this one is heart healthy, thinning the blood in the same way as aspirin. pxs also hold the ip for the main ingredient, some tomato extract. the potential is there as a health drink , but also , i would like to see pxs try to get the airlines interested as it could work combatting deep vein thrombosis. it's a gamble at the moment until some sales figures are in. thanks for your thoughts, much appreciated.

eric, got your email. cheers.

Thanks bosley.

Yes the drink sounds a lot more promising than squashing a load of fruit
into a carton.

Good luck with this stock.

ravey davey gravy: did you win it? great performance anyhow.

So what's a mere health food drink in comparison to an oil gusher? Somewhat easier to set up in this market than build an oil rig. My early reaction is that there is a lot of groundwork behind this one plus endorsement by HEART UK; also some interesting developments in the 'pipeline'.

Have put my pocket where my mouth is and bought in this morning at 12p. You guys have healthy profits already but I suspect we are still in the early stages of positive newsflow; this is a natural for Mail readers. Three major supermarkets on board without s significant movement in sp.

Eric

bosley - you should fly easyJet. You only get DVT with them if you pay extra for it. lol!

I'm sticking woth PSG on the nutraceuticals front for now. Price is in the dildrums and a good time to accumulate. I believe them to be the SEO of the pharma's with their phosphorylation techniques' extremely wide applications to make exisiting drugs and vitamins water soluble for first time - e.g. morphine (transdermal delivery) and vitamin E (also good for the ticker) - sorry off thread, but interesting to compare with PXS.

sd

"Peter Brabeck, head of Nestle and one of the most influential
people in the food industry, was interviewed in yesterdays Financial
Times:-

"It is my conviction that the next value creation, and it will be huge,
is going to be nutritional aspects. That is what allows you to ask 40%
more for your products".

The article continued that foods with medical benefits, otherwise known
as functional foods or nutraceuticals are expected to be the big source of
growth for the next 15 to 20 years. "

sd, i nicked that from your psg thread a while ago. hope you don't mind but it seemed apt and could reassure eric that there is a resonable margin for pxs. but, until pxs start putting out some figures it's all guesswork really.

Nice one bos. Been put on aspirin to thin the blood but still haven't found Serco; not in our local Waitrose; will check Sainsbury tomorrow.

I liked sd's dildrums - a sort of doggy diddums doldrums! Now, sd, its not a case of either/or but of both/and. What we need is an sd-type analysis of the potential revenue/profit. Think I'll visit the web-site and try to sniff it out for myself.

Eric